Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA)
Clinical trial NCT05698017 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05698017
- Sponsor
- Cytora Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-07
- Primary completion
- 2026-02-19
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.